# Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

> **NCT00947557** · PHASE3 · TERMINATED · sponsor: **Forest Laboratories** · enrollment: 677 (actual)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** Dutogliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00947557
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 677 (ACTUAL)
- **Last updated:** 2011-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947557, "Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00947557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*